We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+15.53%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$38.7B
AUM Growth
+$5.1B
(+15%)
Cap. Flow
+$551M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
1,486
New
101
Increased
869
Reduced
411
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$130M |
| 2 |
Franco-Nevada
FNV
|
+$128M |
| 3 |
B
Barrick Mining
B
|
+$98.9M |
| 4 |
Dominion Energy
D
|
+$96M |
| 5 |
Monolithic Power Systems
MPWR
|
+$88.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$133M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$104M |
| 3 |
SLB Ltd
SLB
|
+$90.4M |
| 4 |
Blackrock
BLK
|
+$89.1M |
| 5 |
Honeywell
HON
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 35.79% |
| 2 | Technology | 25.85% |
| 3 | Energy | 9% |
| 4 | Healthcare | 6.56% |
| 5 | Financials | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Open Text
OTEX
$6.34B
| $197K | ﹤0.01% |
6,671
+1,011
| +18% | +$28.7K |
|
|
JWN
1102
DELISTED
Nordstrom
JWN
| $196K | ﹤0.01% |
+12,121
| New | +$232K |
|
|
TCN
1103
DELISTED
Tricon Residential Inc.
TCN
| $195K | ﹤0.01% |
25,300
+11,236
| +80% | +$93.8K |
|
1104
Exponent
EXPO
$3.31B
| $194K | ﹤0.01% |
1,953
+237
| +14% | +$23K |
|
|
NNDM
1105
Nano Dimension
NNDM
$328M
| $194K | ﹤0.01% |
84,407
+10,700
| +15% | +$26K |
|
1106
NetApp
NTAP
$35.9B
| $194K | ﹤0.01% |
3,230
-20
| -0.6% | -$1.33K |
|
|
KW
1107
DELISTED
Kennedy-Wilson Holdings
KW
| $193K | ﹤0.01% |
12,246
+5,439
| +80% | +$87.4K |
|
1108
Curtiss-Wright
CW
$27.6B
| $192K | ﹤0.01% |
1,148
+103
| +10% | +$17.2K |
|
1109
Expedia Group
EXPE
$35.8B
| $189K | ﹤0.01% |
+2,153
| New | +$204K |
|
|
SF
1110
Stifel
SF
$12.7B
| $189K | ﹤0.01% |
4,857
+246
| +5% | +$9.73K |
|
1111
Tanger
SKT
$4.68B
| $189K | ﹤0.01% |
10,515
+4,670
| +80% | +$83.8K |
|
1112
Tandem Diabetes Care
TNDM
$1.38B
| $189K | ﹤0.01% |
4,197
+3,366
| +405% | +$152K |
|
1113
Inspire Medical Systems
INSP
$1.5B
| $188K | ﹤0.01% |
+746
| New | +$159K |
|
1114
Smith & Nephew
SNN
$13.5B
| $188K | ﹤0.01% |
+6,985
| New | +$175K |
|
|
ROIC
1115
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $188K | ﹤0.01% |
12,506
+5,554
| +80% | +$81.4K |
|
1116
CareTrust REIT
CTRE
$9.74B
| $186K | ﹤0.01% |
10,014
+4,448
| +80% | +$83K |
|
1117
Insperity
NSP
$2.05B
| $186K | ﹤0.01% |
+1,641
| New | +$186K |
|
1118
Boise Cascade
BCC
$2.92B
| $184K | ﹤0.01% |
2,680
+286
| +12% | +$19.5K |
|
1119
EXL Service
EXLS
$5.19B
| $183K | ﹤0.01% |
5,400
+615
| +13% | +$21.4K |
|
1120
Federated Hermes
FHI
$4.77B
| $183K | ﹤0.01% |
5,042
+3,179
| +171% | +$112K |
|
1121
Acuity Brands
AYI
$10B
| $182K | ﹤0.01% |
1,100
+62
| +6% | +$11K |
|
1122
Invesco
IVZ
$13.6B
| $182K | ﹤0.01% |
10,094
+537
| +6% | +$9.19K |
|
1123
UFP Industries
UFPI
$5.18B
| $181K | ﹤0.01% |
2,287
+253
| +12% | +$19.3K |
|
1124
Brunswick
BC
$5.16B
| $180K | ﹤0.01% |
2,498
+156
| +7% | +$11.1K |
|
1125
Opko Health
OPK
$978M
| $180K | ﹤0.01% |
144,164
+2,229
| +2% | +$3.51K |
|
Similar funds
VanEck Associates's Q4 2022 Portfolio in Review
As of Q4 2022, VanEck Associates held 1,486 positions worth $38.7B, up 15% from $33.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
VanEck Associates's Q4 2022 filing shows 101 new, 869 increased, 411 reduced and 62 closed positions. Its largest new stake was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M. The largest sale was Gilead Sciences, an estimated $133M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, up from 34% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q4 2022 buy was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M.
- VanEck Associates added most to Newmont in Q4 2022, an estimated $130M increase.
- VanEck Associates's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $133M.
- VanEck Associates fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q4 2022, selling an estimated $29.4M.
- VanEck Associates's ten largest holdings make up 24% of its $38.7B portfolio in Q4 2022.
- VanEck Associates opened 101 new positions and closed 62 in Q4 2022.
- VanEck Associates's portfolio value rose 15% quarter-over-quarter to $38.7B.
Based on VanEck Associates's 13F filing for Q4 2022, filed 8 Feb 2023.